Clinical Trial Update: Dialysate Sodium Individualization in Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dialysate sodium individualization in hemodialysis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Snippet

Sponsor: Yale University | Conditions: Hypertension, Hemodialysis Patients | Phase 1 | Status: TERMINATED